Y.A. Kucheryavy, N.V. Petrova, T.S. Oganesyan, Z.F. Tibilova, A.V. Smirnov
Hereditary Pancreatitis: From History To New Discoveries
|
№12 / 2011
|
I.V. Mayev, A.N. Kazyulin, Ye.K. Baranskaya, Yu.A.Kucheryavy, A.B. Moskaleva
Nutritional Disorders As A Causative Factor Of Development And The Aggravation Of Pancreatitis
|
№12 / 2011
|
I.V. Mayev, A.N. Kazyulin, Ye.K. Baranskaya, Yu. A.Kucheryavy, A.B. Moskaleva
Nutritional Disorders As A Causative Factor For Development And Aggravation Of Pancreatitis
|
№11 / 2011
|
Maev I.V., Sviridova A.V., Kucheryavyi U.A., Goncharenko A.U., Samsonov A.A., Oganesyan T.S., Ustinova N.N., Kazulin A.N., Troshina I.V., Moskaleva A.B.
Long-lasting Enzyme Replacement Therapy With Different Pancreatin Preparations In Patients With Chronic Pancreatitis And Exocrine Pancreatic Insufficiency
|
№2 / 2011
|
I.V. Maev, Y.A. Kucheryavyi, T.S. Oganesyan, A.B. Moskalyova, I.V. Troshina, N.N. Ustinova, N.S. Kulikovskaya
Pharmacoeconomic Effectiveness Of Replacement Therapy With Different Preparations Of Pancreatine In Patients With Chronic Pancreatitis With Exocrine Pancreatic Insufficiency
|
№15 / 2010
|
V.A. Maximov, S.Ye. Buntin, V.G. Buntina
Impact Of Odeston On Exocrine Pancreatic Function In Patients With Chronic Pancreatitis
|
№15 / 2010
|
Maev I.V., KucheryavyY.A., Moskaleva A.B.
Chronic Pancreatitis: Myths And Realities
|
№12 / 2010
|
I. Maev, Y. Kucheryavyi, T.Oganesyan, A. Sviridova, I. Troshina, N. Ustinova, A. Moskaleva
Enzyme Supplementation Therapy Of Exocrine Pancreatic Deficiency With Pancreatin Preparations: Retrospective Pharmacoeconomic Studies
|
№10 / 2010
|
V. Grinevich, E.Sas, F.Karev, A.Tryapitsyn, D.Egorov
Dynamics Of Certain Metabolic Alterations At The Background Of Therapy With The Use Of Selective M-cholinolytics (hyoscine Butylbromide) In Patients With Chronic Pancreatitis
|
№2 / 2010
|
V.A. Maximov, S.E. Buntin, V.G. Buntina
Efficacy Of Odeston In The Treatment Of Patients With Chronic Pancreatitis
|
№13 / 2009
|
T.S. Mischurovskaya, E.A. Belousova
We Present The Results Of Clinical Assessment For Applicability Of Buscopan (hyoscine Butilbromide) In The Treatment Of Chronic Pancreatitis With Pain Syndrome. In The Study, Including 52 Patients, Buscopan Significantly Reduced The Pain Intensity In A Pe
|
№13 / 2009
|